130 related articles for article (PubMed ID: 29545453)
1. Increased Prevalence of Thyroid Disease in Patients with Antineutrophil Cytoplasmic Antibodies-associated Vasculitis.
Prendecki M; Martin L; Tanna A; Antonelou M; Pusey CD
J Rheumatol; 2018 May; 45(5):686-689. PubMed ID: 29545453
[TBL] [Abstract][Full Text] [Related]
2. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese patients.
Xu PC; Chen M; Zhao MH
Clin Exp Nephrol; 2013 Oct; 17(5):705-707. PubMed ID: 23180038
[TBL] [Abstract][Full Text] [Related]
6. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
7. Development of anti-neutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease independent of anti-thyroid drug therapy.
Khan NA; Singh M
Mod Rheumatol; 2012 Sep; 22(5):778-82. PubMed ID: 22167487
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with anti-thyroid drug treatment.
D'Cruz D; Chesser AM; Lightowler C; Comer M; Hurst MJ; Baker LR; Raine AE
Br J Rheumatol; 1995 Nov; 34(11):1090-1. PubMed ID: 8542214
[TBL] [Abstract][Full Text] [Related]
9. PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect?
Bilge NS; Kaşifoğlu T; Korkmaz C
Rheumatol Int; 2013 Jan; 33(1):117-20. PubMed ID: 22228488
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
11. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
12. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
[TBL] [Abstract][Full Text] [Related]
13. [Antineutrophil cytoplasmic antibody associated vasculitis: an uncommon side effect of propylthiouracil].
Pasquet F; Pavic M; Mounier C; Karkowski L; Colle B
Rev Med Interne; 2009 Oct; 30(10):882-5. PubMed ID: 19740576
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
15. [Antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis associated to the use of propylthiouracil. Report of four cases].
Hidalgo V S; Silva A P; Undurraga S F; Soto I N; Marinovic M MA
Rev Med Chil; 2006 Apr; 134(4):475-80. PubMed ID: 16758084
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy.
Yuasa S; Hashimoto M; Yura T; Sumikura T; Takahashi N; Shoji T; Uchida K; Fujioka H; Kihara M; Matsuo H
Nephron; 1996; 73(4):701-3. PubMed ID: 8856275
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication.
Gunton JE; Stiel J; Clifton-Bligh P; Wilmshurst E; McElduff A
Eur J Endocrinol; 2000 Jun; 142(6):587. PubMed ID: 10822221
[TBL] [Abstract][Full Text] [Related]
18. Concomitant drug- and infection-induced antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis with multispecific ANCA.
Kontic M; Radovanovic S; Nikolic M; Bonaci-Nikolic B
Med Princ Pract; 2012; 21(5):488-91. PubMed ID: 22538212
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
Chen M; Gao Y; Guo XH; Zhao MH
Nat Rev Nephrol; 2012 Jun; 8(8):476-83. PubMed ID: 22664738
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N
Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
